https://www.capricor.com/investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/capricor/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.capricor.com/investors/news-events/press-releases/detail/340/capricor-therapeutics-reports-fourth-quarter-and-full-year Thu, 12 Mar 26 16:01:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/340/capricor-therapeutics-reports-fourth-quarter-and-full-year https://www.capricor.com/investors/news-events/press-releases/detail/339/capricor-therapeutics-announces-late-breaking-hope-3-data Thu, 12 Mar 26 09:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/339/capricor-therapeutics-announces-late-breaking-hope-3-data https://www.capricor.com/investors/news-events/press-releases/detail/338/capricor-therapeutics-announces-establishment-of-new-pdufa Tue, 10 Mar 26 09:25:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/338/capricor-therapeutics-announces-establishment-of-new-pdufa https://www.capricor.com/investors/news-events/press-releases/detail/337/capricor-therapeutics-to-present-fourth-quarter-and-full Mon, 09 Mar 26 08:30:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/337/capricor-therapeutics-to-present-fourth-quarter-and-full https://www.capricor.com/investors/news-events/press-releases/detail/336/capricor-therapeutics-announces-late-breaking-presentation Tue, 24 Feb 26 09:00:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/336/capricor-therapeutics-announces-late-breaking-presentation https://www.capricor.com/investors/news-events/press-releases/detail/335/capricor-therapeutics-provides-regulatory-update-on Tue, 20 Jan 26 09:15:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/335/capricor-therapeutics-provides-regulatory-update-on https://www.capricor.com/investors/news-events/press-releases/detail/334/capricor-therapeutics-and-parent-project-muscular-dystrophy Tue, 16 Dec 25 16:05:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/334/capricor-therapeutics-and-parent-project-muscular-dystrophy https://www.capricor.com/investors/news-events/press-releases/detail/333/capricor-therapeutics-announces-pricing-of-150-million Fri, 05 Dec 25 06:15:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/333/capricor-therapeutics-announces-pricing-of-150-million https://www.capricor.com/investors/news-events/press-releases/detail/332/capricor-therapeutics-announces-proposed-public-offering-of Thu, 04 Dec 25 16:01:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/332/capricor-therapeutics-announces-proposed-public-offering-of https://www.capricor.com/investors/news-events/press-releases/detail/331/capricor-therapeutics-announces-positive-topline-results Wed, 03 Dec 25 07:20:00 -0500 https://www.capricor.com/investors/news-events/press-releases/detail/331/capricor-therapeutics-announces-positive-topline-results